Regan Joseph, Smalley Matthew
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.
Stem Cell Rev. 2007 Jun;3(2):124-36. doi: 10.1007/s12015-007-0017-3.
Prospective isolation and in vitro and in vivo analysis of primary mouse mammary epithelial cells has been used to separate cell subpopulations and identify stem, progenitor and differentiated cell compartments. Progress has been made from cell separation strategies based on a single marker of the luminal epithelial or myoepithelial compartments to use of markers that allow simultaneous isolation of non-epithelial, basal/myoepithelial and luminal epithelial cells. Transplant analysis has shown that mammary stem cells are found in the basal/myoepithelial compartment, whereas in vitro colony progenitors are found in the luminal compartment. A basal population enriched for stem cell activity can be purified from the myoepithelial cells and the most recent data shows that the luminal population can now be prospectively split into estrogen receptor positive and estrogen receptor negative cells. Future work aims to molecularly characterise these populations to identify new drug targets, which can be used to specifically kill breast cancer stem cells.
对原代小鼠乳腺上皮细胞进行前瞻性分离以及体外和体内分析,已用于分离细胞亚群并鉴定干细胞、祖细胞和分化细胞区室。从基于腔上皮或肌上皮区室单一标志物的细胞分离策略,发展到使用能够同时分离非上皮细胞、基底/肌上皮细胞和腔上皮细胞的标志物,已经取得了进展。移植分析表明,乳腺干细胞存在于基底/肌上皮区室,而体外集落祖细胞存在于腔区室。富含干细胞活性的基底细胞群体可从肌上皮细胞中纯化出来,最新数据表明,现在可以将腔细胞群体前瞻性地分为雌激素受体阳性和雌激素受体阴性细胞。未来的工作旨在对这些群体进行分子特征分析,以确定新的药物靶点,从而可用于特异性杀死乳腺癌干细胞。